UK: problems with Primary Care Groups and Trusts identified

2 August 2001

The UK National Health Service's progress in establishing Primary CareGroups and Trusts has been rapid. But research published late-July by the School of Pharmacy, University of London (entitled Valuing Food Practices), indicates that as PCTs become bigger, more complex organizations, they are in danger of losing local practitioner involvement, and their focus on making "natural community" level improvements in primary care.

To succeed, each PCT must itself become "a strong voice for primary care," says the research, which finds that many PCG and PCT managers have felt isolated and uncertain of their ability - by themselves - to meet the challenges facing them.

Copies of the report are available from the Centre for Practice and Policy Paper 2 (priced at L5 plus L1 postage and packaging). The School of Pharmacy, University of London, 29-39 Brunswick Square, London WC1N 1AX, UK.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight